vidarabine phosphate has been researched along with Leukemia L5178 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernd, A; Gramzow, M; Kurelec, B; Müller, WE; Nitzgen, DE; Schröder, HC; Zahn, RK | 1 |
| Capizzi, RL; Kucera, GL | 1 |
2 other study(ies) available for vidarabine phosphate and Leukemia L5178
| Article | Year |
|---|---|
Inhibition of nuclear envelope nucleoside triphosphatase-regulated nucleocytoplasmic messenger RNA translocation by 9-beta-D-arabinofuranosyladenine 5'-triphosphate in rodent cells.
Topics: Animals; Arabinonucleotides; Kinetics; Leukemia L5178; Mice; Nuclear Envelope; Nucleoside-Triphosphatase; Phosphoric Monoester Hydrolases; Poly A; RNA, Messenger; RNA, Neoplasm; Vidarabine Phosphate | 1984 |
1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
Topics: Animals; Choline-Phosphate Cytidylyltransferase; Cytarabine; Cytidine Diphosphate Choline; Diacylglycerol Cholinephosphotransferase; Leukemia L5178; Nucleotidyltransferases; Vidarabine Phosphate | 1992 |